Cx601

darvadstrocel · TiGenix S.A.U.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cx601, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) [Phase 3]

See pricing